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Minimally	 invasive	 surgery	 (laparoscopic,	 robotic,	 transanal)	 has	 evolved	 and	
expanded	considerably,	especially	 in	 the	 last	30	years.	 	 It	 is	 important	 to	point	
out	 that	 the	 potential	 advantages	 of	 a	minimally	 invasive	 approach	 go	 beyond	
smaller	 incision	size.	Reduced	 interference	with	body	homeostasis	has	positive	
impacts	both	in	the	clinical	(less	systemic	inflammatory	response	to	surgery,	less	
complications,	 shorter	 hospital	 stay)	 and	 social	 spheres	 (less	 work	 and	 social	
inactivity,	 less	disability,	 less	 fear	 and	 anxiety).	 In	 some	ways,	 geriatric,	 obese,	
and	 otherwise	 vulnerable	 patients	 may	 experience	 a	 greater	 reduction	 in	
morbidity	that	their	younger,	healthier	counterparts.	























Aim	The	 literature	 has	 shown	 that	 robotic	 proctectomy	 for	 rectal	 cancer	 (RC)	
may	result	in	wider	circumferential	resection	margins	(CRM)	when	compared	to	
its	open	and	 laparoscopic	 counterpart.	The	aim	of	 the	study	was	 to	 revisit	 this	
evidence,	particularly	 in	high-risk	patients.	The	secondary	aim	was	 to	compare	
30-day	outcomes	in	the	three	groups.	
Methods	 The	 first	 60	 unselected	 consecutive	 patients	 with	 RC	 undergoing	
robotic	proctectomy	by	one	surgeon	were	prospectively	collected	during	3	years.	
Patients	 undergoing	 open	 or	 laparoscopic	 proctectomy	 were	 matched	 for	
gender,	 body	 mass	 index	 (BMI),	 and	 tumor	 distance	 from	 the	 anal	 verge.	
Pathologists	were	blind	to	surgical	access.	
Results	Demographics	 data,	 tumor	 characteristics	 and	 the	 rate	 of	 neoadjuvant	
therapy	 did	 not	 differ	 in	 the	 three	 groups.	 Type	 of	 resection	 (low	 anterior	 or	
abdominoperineal)	 and	 the	 rate	 of	 stoma	 creation	 did	 not	 differ	 (p=1.00	 and	




CI	0.003–0.99;	p=0.035).	OR	 time	was	 significantly	 longer	 in	 the	 robotic	 group	
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(<0.001).	The	time	of	resumption	of	solid	diet,	the	length	of	hospital	stay	and	the	
rate	of	complications	were	significantly	 lower	 in	the	minimally	 invasive	groups	
(laparoscopic	 and	 robotic).	 A	 lower	 rate	 of	 patients	 in	 the	 robotic	 group	
experienced	 a	 LOS	 >	 6	 days	 (p<0.001).	 TME	 quality	 (p=0.787),	 distal	 margin	
(0.790)	 and	 pTN	 stage	 (p=0.966)	 were	 comparable.	 The	 number	 of	 harvested	
nodes	was	significantly	higher	in	the	minimally	invasive	approaches	(robotic	or	
laparoscopic)	(p=	0.001).		After	performing	a	DSCF	test	for	multiple	comparisons	






Conclusion	 The	 results	 of	 this	 study	 show	 two	 significant	 advantages	 of	 the	
robotic	approach,	especially	in	difficult	patients	and	although	the	inclusion	of	the	






New	surgical	 technologies	 aim	 to	overcome	 the	 challenge	of	 the	narrow	pelvic	









previous	 study	 found	 that	 Circumferential	 Resection	 Margins	 (CRMs)	 were	
significantly	wider	when	a	surgeon’s	learning	curve	in	robotic	proctectomy	was	
compared	to	matched	open	and	laparoscopic	RC	cases	by	the	same	surgeon5.	In	
fact,	 robotic	 access	 with	 its	 wristed	 instruments	 may	 allow	 overcoming	 the	
laparoscopic	trocars’	fulcrum	effect,	which	limits	the	range	of	movements	in	the	
confined	 space	 of	 the	 pelvis6	 and	 may	 allow	 to	 achieve	 wider	 CRM,	 a	 metric	
known	 as	 an	 independent	 predictor	 of	 cancer-specific	 survival	 at	multivariate	
analysis7.		
The	 primary	 aim	 of	 this	 study	was	 to	 revisit	 the	 evidence	 suggesting	 that	 the	
width	 of	 CRMs	may	 be	 increased	 by	 robotic	 proctectomy	 as	 compared	 to	 the	
open	 and	 laparoscopic	 counterpart	 performed	 by	 the	 same	 surgeon	 in	
unselected	consecutive	patients	with	RC	and	to	perform	a	subgroup	analysis	for	











analyzed	 from	 the	 prospectively	 maintained	 database	 of	 the	 Unit	 of	 Digestive	
Surgery,	 Careggi	University	Hospital,	 Florence.	 Inclusion	 criteria	were	 elective,	
curative-intent	surgery	for	rectal	adenocarcinoma	performed	by	one	surgeon	at	
one	 institution.	 Exclusion	 criteria	 were	 stage	 IV	 or	 recurrent	 disease	 and	
emergency	 surgery.	 RC	 was	 defined	 as	 adenocarcinoma	 located	 within	 12	 cm	
from	 anal	 verge.	 The	 primary	 study	 endpoint	 was	 the	 width	 of	 the	 CRMs	
evaluated	 according	 to	 Quirke	 et	 al	 8.	 Pathologists	 were	 blinded	 to	 surgical	
access.	The	American	Society	of	Anesthesiology	classification	 9	was	used	 in	 the	
preoperative	 assessment	 although	 it	 does	 not	 predict	 the	 risk	 for	 a	 particular	
patient.	The	Colorectal	Physiological	and	Operative	Severity	Score	for	evaluation	
of	Morbidity	and	mortality	(CR-POSSUM)	instead	was	used	to	estimate	the	risk	of	
morbidity	 and	mortality	 of	 each	 patient10.	 BMI	 was	 defined	 as	 weight	 (in	 kg)	




Group	 of	 RC	 and	 assessed	 for	 patients	 undergoing	 restorative	 surgery12.	
Postoperative	ileus	was	defined	as	postoperative	prolonged	(>	3	days)	nil	per	os	
or	need	of	 nasogastric	 tube	 insertion.	Ultralow	anterior	 resection	 (u-LAR)	was	
defined	as	a	TME	with	anastomosis	<	5	 cm	 from	 the	anal	verge.	Conversion	 to	
open	 surgery	was	 defined	 as	 an	 abdominal	 incision	 to	 continue	 the	 procedure	
under	direct	visualization	before	 full	mobilization	of	 the	rectum.	Complications	
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Continuous	 variables	 were	 reported	 as	 mean	 (standard	 deviation)	 or	 median	
(interquartile	 range);	 categorical	 variables	 as	 frequencies	 and	 percentage.	
Significant	 differences	 between	 the	 two	 groups	were	 tested	 by	 Pearson	X2	 for	
categorical	 variables	 or	 the	 nonparametric	 Kruskal-Wallis	 test	 for	 continuous	
variables.	The	Dwass-Steel-Critchlow-Fligner	(DSCF)	 test	was	used	 for	multiple	
comparison	analysis	between	groups.	
All	 tests	 were	 two-sided	 and	 p	 <	 0.05	 was	 considered	 statistically	 significant.	
Subgroups	 analyses	 were	 conducted	 to	 estimate	 the	 odds	 ratios	 (ORs)	 for	
conversion	to	laparotomy	and	CRM	involvement	between	groups.	ORs	and	their	
95%	 confidence	 intervals	 (95%	 CI)	 were	 estimated	 using	 a	 univariate	 logistic	
regression	model.		




Matched	 patients	 in	 the	 3	 groups	were	 comparable	 for	 age	 (p=0.605),	 gender	
(p=0.789),	BMI	(p=0.407),	ASA	class	(p=0.869),	POSSUM	scores	(p=0.683),	pre-
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existing	 comorbidities	 (p=0.498)	 and	 previous	 abdominal	 surgery	 (p=0.587)	
(Table	1).		Tumor	distance	from	anal	verge	(p=0.912),	tumor	location	(p=0.976),	
preoperative	 stage	 (p=668)	 and	 neoadjuvant	 chemoradiation	 (p=0.517)	 were	
similar	 in	 the	 3	 groups.	 (Table	 2).	 OR	 time	 was	 longer	 in	 the	 robotic	 group	
(p<0.0001).	The	rate	of	conversion	to	open	was	higher	in	the	laparoscopic	group	
(p=0.039).	 There	 was	 no	 difference	 in	 stoma	 creation	 (p=0.974)	 and	 type	 of	
resection	 (p=1.000)	 (Table	 3).	 The	 mean	 postoperative	 day	 of	 resumption	 of	
solid	diet	 (p<0.001)	and	 length	of	hospital	 stay	 (LOS)	 (p<0.001)	were	 lower	 in	
the	robotic	and	laparoscopic	groups.	A	lower	rate	of	patients	in	the	robotic	group	
experienced	a	LOS	>	6	days	(p<0.001).	(Table	4).	There	were	no	deaths	up	to	30	
days	 after	 surgery.	 The	 overall	 rate	 of	 complications	 was	 higher	 in	 the	 open	
group	(p<0.001),	this	significance	was	determined	by	the	rate	of	Superficial	Site	
Infections	 (SSI)	 (p=0.001).	 Readmissions	 (p=0.561)	 and	 complications	 grade	
according	 to	 Clavien-Dindo	 classification	 (p=0.685)	 were	 comparable	 in	 the	 3	
groups	(Table	4).		





rate	 and	 CRM	 <	 2	 mm	 was	 performed	 for	 at-risk	 subgroups	 (male	 patients,	
patients	undergoing	ultralow	anterior	resection:	u-LAR,	obese	patients).	The	risk	
of	conversion	was	significantly	higher	in	the	laparoscopic	group	for	male	gender	








The	 results	 of	 this	 study	 show	 two	 significant	 advantages	 of	 the	 robotic	
approach:	 lower	 rate	 of	 CRMs	 <	 2	 mm	 in	 males	 and	 obese	 patients,	 lower	




the	 minimally	 invasive	 (robotic	 and	 laparoscopic)	 vs	 the	 open	 approach.	
Operative	time	was	significantly	longer	in	the	robotic	approach,	with	a	trend	to	
shorten	 and	 to	 be	 comparable	 to	 that	 of	 the	 other	 two	 approaches	 during	 the	
surgeon’s	learning	curve.	
Differently	 from	a	 previously	 published	 study5,	which	 reported	wider	 CRMs	 in	
the	 robotic	 group	 over	 the	 laparoscopic	 and	 open	 approaches,	 in	 the	 present	
study	CRMs	 resulted	 significantly	wider	 in	 the	minimally	 invasive	 groups	 over	
the	open.	Interestingly,	robotic	surgery	resulted	an	independent	factor	for	wider	
CRM	 in	 at-risk	 subgroups	 such	 as	 males	 and	 obese	 patients.	 The	 robotic	
approach	to	RC	may	help	to	perform	an	oncological	good	dissection	thanks	to	its	
endo-wrist	technology	overcoming	the	fulcrum	effect	in	the	pelvis	as	previously	
reported	 by	 a	 consensus	 conference6.	 A	 study	 analyzing	 400	 consecutive	
laparoscopic	and	robotic	TMEs	did	not	report	an	association	between	approach	




CRM	 involvement	 varies	 from	 greater	 than	 1	mm15,16	 to	 greater	 than	 2	mm17.	
This	 lack	 of	 standardization	 leads	 to	 controversial	 results	 with	 some	 authors	
reporting	no	significant	differences	in	CRM	involvement	between	the	robotic	and	
laparoscopic	 approach	 15,16,18,19-21,	 whereas	 others	 reported	 significantly	
decreased	CRM	involvement	after	robotic	proctectomy	5,	22.	In	2002,	Nagtegaal	et	
al	 reported	 that	 local	 recurrence	 and	 liver	metastases	 rates	were	 significantly	




and	 laparoscopic	 cancer	 cases	 by	 the	 same	 surgeon	 (10.5	mm	 vs.	 8	mm	 vs.	 4	
mm)5.	Another	study	reported	significantly	wider	CRM	after	robotic	TME	when	
compared	to	transanal	Total	Mesorectal	Excision	(TaTME)	although	there	were	
not	 differences	 in	 the	 quality	 of	 TME,	 tumor	 size,	 tumor	 location	 and	
preoperative	 neoadjuvant	 therapy.	 Authors	 concluded	 that	 a	 potential	
explanation	 is	 the	greater	precision	of	 the	 robotic	approach24.	Nonetheless,	we	
still	do	not	know	the	potential	clinical	significance	of	a	CRM	wider	than	2	mm.	A	
study	reported	a	significant	increasing	trend	in	recurrence	free	survival	after	RC	
surgery	when	patients	were	divided	 according	 to	CRM	width:	 <	1	mm,	1.1	 –	5	
mm,	>	5	mm25	pointing	at	CRM	as	a	predictor	of	cancer-specific	survival7.	More	




The	 robotic	 approach	was	 associated	with	 lower	 conversion	 rates	 and	was	 an	
independent	predictor	 in	male	patients	and	 in	patients	undergoing	u-LAR.	This	
data	 is	 also	 reported	 two	 recent	 series14,26	 and	 by	 two	 meta-analysis27,28,	
although	results	 from	the	 largest	RCT	available	on	robotic	RC	surgery	 failed	 to	
prove	its	superiority	over	laparoscopy29.	
Robotic	surgery	was	associated	with	prolonged	operative	time	in	our	series	and	
this	 is	 consistent	 with	 previous	 evidence30.	 However,	 it	 should	 be	 underlined	
that	 the	 robotic	 group	 included	 operations	 performed	 during	 the	 surgeon’s	
learning	curve	and	that	after	the	first	20	cases	operating	time	had	a	tendence	to	
shorten	 becoming	 comparable	 to	 the	 one	 of	 the	 open	 and	 laparoscopic	
approaches.	Operating	time	has	been	the	subject	of	several	studies	attempting	at	
defining	the	optimal	number	of	robotic	proctectomies	required	to	overcome	the	
learning	 curve5.	 The	 literature	 seems	 to	 indicate	 that	 the	 required	 number	 of	
cases	 would	 range	 from	 15	 to	 25	 robotic	 proctectomies	 depending	 on	 the	








balanced	 by	 favorable	 outcomes37.	 Although	 intraoperative	 outcomes	 are	





LOS	 >	 6	 days	 in	 the	 robotic	 group.	 	 This	 could	 be	 due	 to	 the	 advantages	 of	
minimally	invasive	surgery	itself	and	to	the	application	of	the	enhanced	recovery	
program	 in	more	 than	 90%	 of	 patients	 in	 both	 groups.	 Interestingly,	 a	 recent	
study26	 comparing	 317	 consecutive	 robotic	 and	 283	 consecutives	 laparoscopic	
proctectomies	demonstrated	 improved	short-term	outcomes	 in	 terms	of	 length	
of	 stay	 and	 complications	 in	 the	 robotic	 over	 the	 laparoscopic	 approach,	 even	
after	logistic	regression	analysis.		
The	 main	 limitations	 of	 this	 study	 are	 its	 retrospective	 and	 nonrandomized	
setting.	The	first	60	consecutive	robotic	proctectomies	were	matched	with	open	
and	 laparoscopic	cases	extracted	 from	the	surgeon’s	database.	Therefore,	 there	
could	 be	 an	 inherent	 risk	 of	 selection	 bias	 and	 results	 must	 be	 interpreted	
accordingly.	However,	the	matching,	the	consecutive	inclusion	of	robotic	patients	





for	 difficult	 patients,	 although	 the	 inclusion	 of	 the	 surgeon’s	 learning	 curve.	
Surely,	 surgeon’s	 experience	 plays	 a	 major	 role	 in	 the	 results	 of	 a	 technique.	














































































































































































OR	time	(min)		 240	±	50.3	 220.2	±	54.6	 315.7	±	76.7	 <0.0001	






























Solid	Diet	(POD)				 5	(4-7)	 2	(2-3)	 2	(1-3)	 <	0.001*	
Length	of	Stay	(days)			 11	(10-13)	 4	(4-7)	 3	(3-5)	 <	0.001*	




































Readmissions	 10	(16.6)	 8	(13.3)	 6	(10)	 0.561	

















































































Distal	Margin	(mm)				 21.5	±	15.12	 21.5	±	15.12	 20.5	±	16.46	 0.790	






















(male	 patients,	 patients	 undergoing	 ultralow	 anterior	 resection,	 obese	 patients,	
neoadjuvated	patients)	







































































An	 easier	 option	 for	 “invisible	 scar”	 thyroidectomy:	 Hybrid-TransOral	





Background:	 Transoral	 endoscopic	 thyroidectomy	 vestibular	 approach	
(TOETVA)	is	currently	the	only	“cervical	invisible	scar”	procedure	with	a	surgical	
access	close	to	the	thyroid	area.	The	aim	of	this	technical	note	was	to	describe	a	




Access	 (H-TOETSA)	was	 assessed	 in	22	patients	meeting	 the	 inclusion	 criteria.	
Differently	from	TOETVA,	a	central	trocar	(<	10	mm)	for	the	camera	was	placed	
on	 the	natural	 skin	depression	 immediately	under	 the	 chin.	A	 left	3	mm	and	a	
right	5	mm	(or	3	mm	if	a	3	mm	energy	device	was	available)	trocars	were	placed	
in	the	vestibulum	(as	in	TOETVA).		
Results:	 operative	 time	 was	 74,32	 (+	 34,16)	 min.	 Two	 temporary	 recurrent	
nerve	paralysis	and	three	lip/chin	dysesthesia	were	observed.	In	two	patients	an	
additional	 3	 cm	 horizontal	 access	 was	 performed	 2	 cm	 above	 the	 clavicle	 to	
control	 a	 persistent	 bleeding.	 Patients	 complained	 pain	 only	 in	 the	 first	
postoperative	 hours.	 All	 patients	 perceived	 excellent	 cosmetic	 results	 even	 at	
postoperative	day	1.		
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century.	 Technological	 progress,	 indications	 for	 surgery	 at	 lower	 thyroid	
volumes	and	increasing	attention	to	the	aesthetic	results	led	to	the	development	
of	 less	 invasive	 operations:	 shorter	 neck	 incisions	 (i.e.	 minimally	 invasive	
thyroidectomy	 –	 MIT	 –	 incision	 <	 6	 cm	 or	 minimally	 invasive	 video-assisted	
thyroidectomy	 –	 MIVAT	 –	 incision	 <	 2	 cm)	 ,	 reduced	 neck	 dissection,	 extra	
cervical	 approaches	 (i.e.	 robotic	 transaxillary).	 However,	 these	 supposed-to-be	
less	 invasive	 operations	 were	 not	 always	 minimally	 invasive	 nor	 they	
guaranteed	 the	 expected	 aesthetic	 results	 with	 high	 costs	 and	 long	 operative	
time.	Additionally,	as	large	or	multiple	surgical	incisions	were	outside	the	neck,	
wide	 dissection	 was	 required	 to	 overcome	 the	 distance	 between	 the	 surgical	
access	 and	 the	 gland.	 These	 reasons,	 together	 with	 the	 diffusion	 of	 the	
endoscopic	and	robotic	approaches,	led	to	increasing	operative	time	and	costs.		
The	 transoral	 endoscopic	 thyroidectomy	 vestibular	 approach	 (TOETVA)	 is	 the	
latest	 proposed	 operation	 and	 is	 currently	 the	 only	 “scarless”	 or	 more	
appropriately	 “hidden	 and	 invisible	 scar”	 technique.	 TOETVA	 follows	 all	 the	
steps	of	a	conventional	thyroidectomy	having	the	advantage	of	a	surgical	access	
close	to	the	thyroid	area1-2.	Additionally,	the	central	trocar	for	the	camera	allows	
a	 good	 view	 of	 both	 the	 thyroid	 loggias.	 This	 technique	 does	 not	 require	
dedicated	 endoscopic	 or	 robotic	 instruments,	 which	 are	 expensive	 and	 not	
always	available3.		
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The	 aim	 of	 this	 technical	 note	 was	 to	 describe	 our	 experience	 on	 a	 hybrid	
procedure	 with	 a	 combined	 vestibular	 and	 submental	 access:	 H-TOETSA	
(Hybrid-TransOral	Endoscopic	Thyroidectomy	Submental	Access).	
Hybrid	TransOral	Endoscopic	Thyroidectomy	Submental	Access	
TOETVA	 was	 introduced	 into	 our	 Unit	 in	 September	 2017	 with	 the	 standard	
technique	 as	 previously	 described	 by	Wang1	 and	 later	modified	 by	 Anuwong2.														
The	main	difficulty	reported	during	our	learning	curve	was	the	placement	of	the	
10	 mm	 central	 trocar	 requiring	 the	 detachment	 of	 the	 chin	 tissue	 from	 the	
mandibular	 periosteum:	 this	 maneuver	 resulted	 in	 postoperative	 painful	
hemorrhagic	infarction	and	prolonged	edema	of	the	lower	lip.	The	placement	of	
the	2	 lateral	 trocars	was	easier,	but	 it	also	could	cause	ecchymosis,	edema	and	
lower	 lip	 dysesthesia.	 Furthermore,	 the	 conflict	 between	 the	 three	 trocars	
caused	 limitations	 in	 the	 movement	 of	 endoscopic	 instruments.	 A	 patient	
scheduled	 for	 TOETVA	 who	 already	 had	 a	 submental	 post-traumatic	 scar,	




skin	 depression	 immediately	 under	 the	 chin	 (Fig	 1).	 From	 this	 site	 a	 5	 mm	
endobag	(Fannin	UK	Limited	T/A	–Espiner	Medical-Clavedon,Somerset-	UK)	was	
also	inserted	for	the	specimen	extraction.	There	are	two	reasons	for	using	a	10-
12	mm	 trocar:	 1)	 an	 incision	 of	 at	 least	 2	 cm	 is	 always	 required	 for	 specimen	
extraction,	2)	the	10-12	mm	trocar	helps	in	lifting	the	miocutaneous	flap	without	
causing	 ischemia	 and	 decubitus	 (as	 the	 5	 mm	 trocar	 would	 do	 exerting	 its	
pressure	on	a	smaller	surface).	A	 left	3	mm	trocar	 for	3	mm	laparoscopic	rigid	
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instruments	 (Ab	 Medica	 s.a.s.-Mery	 Sur	 Cher-France)	 and	 a	 right	 5	 mm	 (or	 3	
mm)	 trocar	 for	 the	 energy	 device	 were	 placed	 in	 the	 standard	 vestibular	





22	 H-TOETSAs	 were	 performed	 at	 the	 Unit	 of	 Endocrine	 Surgery,	 Florence	
University	 Hospital.	 Patients’	 data	 were	 prospectively	 registered	 in	 the	 Unit	
database.	 Approval	 by	 the	 ethical	 committee	 and	 informed	 consent	 from	 all	
patients	were	obtained.	
All	 patients	 underwent	 routine	 investigation	 including	 thyroid	 function	 test,	
neck	ultrasonography	and	fine	needle	aspiration.	We	started	our	learning	curve	
performing	 lobectomies	with	 a	 double	 purpose:	 to	 become	 confident	with	 the	
technique	and	to	avoid	longer	operative	times.	
Inclusion	criteria	were	the	same	as	for	TOETVA:	benign	thyroid	nodules	no	more	
than	 4	 cm	 in	 size,	 low	 risk	malignant	 nodules	 no	more	 than	 2	 cm	 in	 size	 and	
goiters	not	exceeding	50	ml	in	volume.	Additionally,	a	strong	patient	motivation	
in	 avoiding	 a	 visible	 cervical	 scar	 was	 mandatory.	 Exclusion	 criteria	 were	
thyroiditis	or	previous	cervical	interventions.	
The	Visual	Analog	Pain	Scale	(VAS)	was	assessed	6	hours	after	the	intervention,	






















hypocalcemia	 was	 not	 registered	 as	 only	 lobectomies	 were	 performed.	 Three	
patients	 complained	 of	 lip/chin	 dysesthesia	 and	 one	 patient	 of	 mild	 lip-chin	
oedema	on	 the	site	of	 the	right	5	mm	vestibular	 trocar,	both	resolved	within	1	








short	 incisions	and	 the	 trauma	due	 to	excessive	skin	 traction,	 is	well	known	 in	
thyroid	 surgery4	 suggesting	 that	 the	 highest	 patient	 satisfaction	 is	 reached	 by	
avoiding	cervical	scars.	
We	performed	H-TOETSA	only	to	the	4.3%	of	patients	(22/502)	as	it	requires	the	




10.	 Our	 initial	 experience	 with	 TOETVA	 confirmed	 its	 feasibility	 and	
reproducibility	 without	 any	 infectious	 or	 permanent	 nerve	 complications.	
However,	 it	 was	 associated	 with	 longer	 operative	 time	 when	 compared	 to	
conventional	 thyroidectomy	 or	 other	 minimally	 invasive	 approaches3,11.	
Preliminary	 data	 comparing	 5	 TOETVAs	 and	 22	 H-TOETSAs	 showed	 a	
significantly	 longer	operative	time	in	the	first	group	(98.7	+	21.7	min	vs	74.3	+	
34.1	 min;	 p<0.05)	 and	 an	 increased	 postoperative	 morbidity	 in	 terms	 of:	
temporary	 lip/chin	 dysesthesia	 (100%	 vs	 13%;	 p<0.05),	 lip/chin	 hematoma	
(40%	vs	0%;	p<0.05),	lip/chin	oedema	(100%	vs	4.5%;	p<0.05),	seroma	(20%	vs	
4.5%).	However,	our	transoral	experience	began	with	performing	the	5	TOETVAs	
which	 represent	 the	 first	 cases	 of	 our	 learning	 curve.	 	 Higher	 numbers	 and	 a	
structured	 prospective	 trial	 are	 needed	 to	 draw	 more	 solid	 conclusions	 in	









the	 first	 case	 we	 perceived	 that	 the	 submental	 approach	 could	 simplify	 the	
procedure	 and	 maintain	 excellent	 aesthetic	 results.	 In	 fact,	 the	 submental	
incision	 is	 already	widely	 used	 in	plastic	 surgery	 for	 neck	 lift	 procedures	with	
excellent	 cosmetic	 results.	 We	 noticed	 that	 even	 before	 complete	 wound	
remodeling,	the	scar	is	already	invisible	thanks	to	its	position.		
After	these	first	22	cases	we	found	the	following	advantages	in	H-TOETSA:	




- It	 increases	 the	 endo-oral	 space	 without	 the	 need	 of	 nasotracheal	
intubation,	often	traumatic	and	cause	of	nasal	mucosal	bleeding;		
- It	avoids	 the	detachment,	often	very	challenging,	of	 the	chin	 tissue	 from	
the	mandibular	periosteum;	
- It	decreases	 lower	 lip	 trauma	and,	consequently,	potential	 lesions	of	 the	
mental	nerves	(medial	branches)	with	a	lower	incidence	of	postoperative	
dysesthesia;	






of	 the	 subplatysmal	 space	 with	 hydrodissection	 and	 blunt	 instruments	
such	as	curved	forceps	and	dilators	of	increasing	diameter;		
- It	 increases	 the	 degree	 of	 movement	 of	 the	 2	 lateral	 trocars	 in	 the	
working	space	thanks	to	the	extra-oral	position	of	the	central	trocar;	
- It	allows	the	insertion	of	the	endobag	directly	through	the	central	access	
(without	 the	 trocar)	 and	 an	 easier	 specimen	 extraction	 as	 it	 is	 not	
prevented	by	the	fixed	and	inflexible	chin.	In	fact,	the	submental	incision	
is	 elastic	 and	 can	 be	 adapted	 to	 the	 specimen	 size,	 extending	 the	
indication	to	goiters	of	higher	volumes.		
- It	 achieves	 excellent	 aesthetic	 results.	 Particularly	 the	use	 of	 two	3	mm	
vestibular	trocars	do	not	leave	any	sign	at	the	end	of	the	procedure.		
- 	It	 decreases	 the	 potential	 risk	 of	 lower	 lip	 and	 surgical	 site	 infections	
thanks	to	the	placement	of	the	central	trocar	outside	the	mouth.	
In	 the	 next	 cases	 we	 expect	 to	 achieve	 a	 decrease	 in	 postoperative	
complications,	 already	 rare	 in	 this	 first	 series.	 The	 aesthetic	 results,	 a	
primary	 endpoint	 in	 this	 intervention,	 were	 good	 even	 after	 7	 days	 from	
surgery.	(Fig	3-4).	
H-TOETSA	 has	 the	 same	 limitations	 as	 TOETVA:	 it	 is	 still	 limited	 to	 low	








A	 further	 implementation	 of	 this	 technique	 consists	 in	 the	 systematic	
adoption	 of	 a	 3	 mm	 vessel	 sealing	 energy	 device	 (JustRight	 Surgical,	
Louisville,	 Colorado-USA)	 and	 a	 3	 mm	 bipolar	 forceps	 (Gunter	 Bissinger	
Medizintechnik	Gmbh,	Teningen-Germany)	allowing	the	placement	of	a	3	mm	
right	 vestibular	 trocar,	 further	 decreasing	 the	 trauma	 and	 improving	 the	
aesthetic	result.	A	3	mm	camera	(ConMed	Corporation,	New	York-USA)	may	
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